Sorafenib-Related Basal Cell Carcinoma

Dermatol Surg. 2021 Sep 1;47(9):1269-1270. doi: 10.1097/DSS.0000000000003096.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Basal Cell / chemically induced*
  • Carcinoma, Basal Cell / surgery*
  • Facial Neoplasms / chemically induced*
  • Facial Neoplasms / surgery*
  • Humans
  • Liver Neoplasms / drug therapy
  • Male
  • Sorafenib / adverse effects*

Substances

  • Antineoplastic Agents
  • Sorafenib